111 related articles for article (PubMed ID: 37187243)
1. G6PD drives glioma invasion by regulating SQSTM1 protein stability.
Zhang X; Wang Z; Zhuo R; Wang L; Qin Y; Han W; Peng X
Gene; 2023 Jul; 874():147476. PubMed ID: 37187243
[TBL] [Abstract][Full Text] [Related]
2. G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.
Yang CA; Huang HY; Lin CL; Chang JG
J Neurooncol; 2018 Sep; 139(3):661-670. PubMed ID: 29845423
[TBL] [Abstract][Full Text] [Related]
3. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
4. G6PD facilitates clear cell renal cell carcinoma invasion by enhancing MMP2 expression through ROS‑MAPK axis pathway.
Zhang Q; Han Q; Yang Z; Ni Y; Agbana YL; Bai H; Yi Z; Yi X; Kuang Y; Zhu Y
Int J Oncol; 2020 Jul; 57(1):197-212. PubMed ID: 32319593
[TBL] [Abstract][Full Text] [Related]
5. ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.
Liu Z; Chen Y; Wang L; Ji S
Neurochem Res; 2021 Nov; 46(11):3003-3011. PubMed ID: 34297301
[TBL] [Abstract][Full Text] [Related]
6. mTORC1 activation induced proximal tubular damage via the pentose phosphate pathway in lupus nephritis.
Mao Z; Tan Y; Tao J; Li L; Yu F; Zhao M
Free Radic Biol Med; 2022 Aug; 189():91-101. PubMed ID: 35863688
[TBL] [Abstract][Full Text] [Related]
7. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis.
Chen B; Hong Y; Gui R; Zheng H; Tian S; Zhai X; Xie X; Chen Q; Qian Q; Ren X; Fan L; Jiang C
Cell Death Dis; 2022 Sep; 13(9):804. PubMed ID: 36127319
[TBL] [Abstract][Full Text] [Related]
9. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
[TBL] [Abstract][Full Text] [Related]
10. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition.
Lu M; Lu L; Dong Q; Yu G; Chen J; Qin L; Wang L; Zhu W; Jia H
Acta Biochim Biophys Sin (Shanghai); 2018 Apr; 50(4):370-380. PubMed ID: 29471502
[TBL] [Abstract][Full Text] [Related]
11. Zoledronic acid inhibits the pentose phosphate pathway through attenuating the Ras-TAp73-G6PD axis in bladder cancer cells.
Wang X; Wu G; Cao G; Yang L; Xu H; Huang J; Hou J
Mol Med Rep; 2015 Sep; 12(3):4620-4625. PubMed ID: 26126921
[TBL] [Abstract][Full Text] [Related]
12. SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.
Coda DM; Lingua MF; Morena D; Foglizzo V; Bersani F; Ala U; Ponzetto C; Taulli R
Cell Cycle; 2015; 14(9):1389-402. PubMed ID: 25644430
[TBL] [Abstract][Full Text] [Related]
13. G6PD inhibits ferroptosis in hepatocellular carcinoma by targeting cytochrome P450 oxidoreductase.
Cao F; Luo A; Yang C
Cell Signal; 2021 Nov; 87():110098. PubMed ID: 34325001
[TBL] [Abstract][Full Text] [Related]
14. G6PD plays a neuroprotective role in brain ischemia through promoting pentose phosphate pathway.
Cao L; Zhang D; Chen J; Qin YY; Sheng R; Feng X; Chen Z; Ding Y; Li M; Qin ZH
Free Radic Biol Med; 2017 Nov; 112():433-444. PubMed ID: 28823591
[TBL] [Abstract][Full Text] [Related]
15. Glucose-6-phosphate dehydrogenase expression is correlated with poor clinical prognosis in esophageal squamous cell carcinoma.
Wang X; Li X; Zhang X; Fan R; Gu H; Shi Y; Liu H
Eur J Surg Oncol; 2015 Oct; 41(10):1293-9. PubMed ID: 26329784
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.
Kathagen-Buhmann A; Schulte A; Weller J; Holz M; Herold-Mende C; Glass R; Lamszus K
Neuro Oncol; 2016 Sep; 18(9):1219-29. PubMed ID: 26917237
[TBL] [Abstract][Full Text] [Related]
17. A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Cai X; Qiu W; Qian M; Feng S; Peng C; Zhang J; Wang Y; Wang Y
Front Cell Dev Biol; 2020; 8():615970. PubMed ID: 33614625
[No Abstract] [Full Text] [Related]
18. GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis.
Xu H; Sun L; Zheng Y; Yu S; Ou-Yang J; Han H; Dai X; Yu X; Li M; Lan Q
Biochem Biophys Res Commun; 2018 Jan; 495(1):446-453. PubMed ID: 29128363
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma.
Zhang Q; Yi X; Yang Z; Han Q; Di X; Chen F; Wang Y; Yi Z; Kuang Y; Zhu Y
J Cancer; 2017; 8(4):665-673. PubMed ID: 28367246
[TBL] [Abstract][Full Text] [Related]
20. m
Liang D; Lin WJ; Ren M; Qiu J; Yang C; Wang X; Li N; Zeng T; Sun K; You L; Yan L; Wang W
Autophagy; 2022 Jun; 18(6):1318-1337. PubMed ID: 34657574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
